Director/PDMR Shareholding
Updated : 13:57
Equiniti Group plc
Incorporated in England and Wales
Registration number: 07090427
LEI: 213800TS721HGE2JIV94
ISIN: GB00BYWWHR75
Equiniti Group plc
(the Company)
Notification of transactions by Persons Discharging Managerial Responsibilities (PDMRs)
The Company has been notified that on 9th October 2019 the following PDMR(s) acquired ordinary shares of £0.001 each at a price of 1.9849 pence per share as follows:
PDMR | Number of shares acquired | Share price |
Guy Wakeley | 5,011 | 1.9849 pence |
This notification is made in accordance with the requirements of the EU Market Abuse Regulation.
Notification of Deal Forms of each PDMRs can be found below.
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||
a) | Name | Guy Wakeley | ||||||
2 | Reason for notification |
| ||||||
a) | Position/Status | Chief Executive/Executive Director | ||||||
b) | Initial notification/amendment | Initial notification | ||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | Equiniti Group plc | ||||||
b) | LEI | 213800TS721HGE2JIV94 | ||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a) | Description of the financial instrument, type of instrument and identification code | Ordinary shares of £0.001 each
ISIN:GB00BYWWHR75 | ||||||
b) | Nature of transaction | Purchase of shares | ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information |
| ||||||
e) | Date of transaction | 9 October 2019 | ||||||
f) | Place of transaction | XLON | ||||||
Enquiries:
Kathy Cong
Company Secretary
Tel: +44(0)20 7469 1800
9th October 2019
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.